跳至主要内容
临床试验/NCT07599462
NCT07599462招募中不适用

Designing and Evaluating Communication for Dual Users of E-cigarettes and Combustible Cigarettes

UNC Lineberger Comprehensive Cancer Center1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2026年4月24日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
90
试验地点
1

研究概览

简要总结

The study is a pilot test of effectiveness of communication campaign ads on interest in quitting combustible cigarettes and e-cigarettes. Over the course of 5 weeks, participants are sent ads that are designed to encourage quitting and then answer surveys.

详细描述

Qualtrics Services will enroll 90 US adult dual users to participate in this study using existing panels. Inclusion criteria are current cigarette and e-cigarette use, age 18 or older, and ability read and answer questions in English, and willingness to receive text messages. Qualtrics will contact, screen, consent and randomize participants into 1 of 2 study arms: exposure to a 3 cycles of 6 ads encouraging them to quit smoking and vaping simultaneously or 6 ads encouraging them to quit sequentially (quitting smoking first followed by quitting vaping). The ads (one per day) are presented along with brief daily surveys. The primary outcome in intent to quit smoking.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • use cigarettes every day or some days
  • use e-cigarettes every day or some days
  • age 18 or older
  • ability to read and answer questions in English

排除标准

  • under age 18

研究组 & 干预措施

Sequential quit messages

Experimental

Participants in this arm receive messages encouraging them to quit cigarettes first, followed by e-cigarettes.

干预措施: communication (Other)

Simultaneous quit messages

Experimental

Participants in this arm receive messages encouraging them to quit both cigarettes and e-cigarettes at the same time.

干预措施: communication (Other)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Pilot Study of Communication for Dual Users of... | 临床试验